WC
VRTX icon

Whitney & Co’s Vertex Pharmaceuticals VRTX Stock Holding History

Whitney & Co’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.7M Sell
44,117
-47
-0.1% -$21.9K 1.64% 17
2025
Q4 		$20M Buy
44,164
+608
+1% +$262K 1.59% 17
2025
Q3 		$17.1M Sell
43,556
-253
-0.6% -$106K 1.55% 19
2025
Q2 		$19.5M Buy
43,809
+14
+0% +$6.45K 1.92% 15
2025
Q1 		$21.2M Buy
43,795
+549
+1% +$256K 2.26% 11
2024
Q4 		$17.4M Sell
43,246
-160
-0.4% -$74.2K 1.83% 16
2024
Q3 		$20.2M Sell
43,406
-7,748
-15% -$3.72M 2.16% 10
2024
Q2 		$24M Buy
51,154
+596
+1% +$259K 2.75% 7
2024
Q1 		$21.1M Buy
50,558
+530
+1% +$224K 2.52% 9
2023
Q4 		$20.4M Buy
50,028
+93
+0.2% +$34.4K 2.63% 6
2023
Q3 		$17.4M Buy
49,935
+405
+0.8% +$142K 2.61% 8
2023
Q2 		$17.4M Sell
49,530
-5,272
-10% -$1.78M 2.51% 6
2023
Q1 		$17.3M Buy
54,802
+1,940
+4% +$582K 2.74% 4
2022
Q4 		$15.3M Buy
52,862
+643
+1% +$196K 2.8% 7
2022
Q3 		$15.1M Buy
52,219
+384
+0.7% +$110K 2.94% 6
2022
Q2 		$14.6M Buy
51,835
+311
+0.6% +$83.2K 2.66% 6
2022
Q1 		$13.4M Buy
51,524
+1,389
+3% +$330K 2.07% 13
2021
Q4 		$11M Buy
50,135
+733
+1% +$143K 1.62% 19
2021
Q3 		$8.96M Buy
49,402
+3,509
+8% +$685K 1.43% 27
2021
Q2 		$9.25M Buy
+45,893
New +$9.6M 1.48% 29

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Whitney & Co's VRTX Position: Q1 2026 in Review

Whitney & Co reduced its Vertex Pharmaceuticals (VRTX) stake by 0.11% in Q1 2026, selling an estimated $21.9K and leaving 44,117 shares worth $19.7M. The position accounts for 1.64% of the portfolio, ranked #17.

Whitney & Co first reported a position in VRTX in Q2 2021 and has held it in 20 quarters since. The position peaked at $24M in Q2 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Whitney & Co held 44,117 shares of Vertex Pharmaceuticals worth $19.7M as of Q1 2026.
  • Whitney & Co sold 47 Vertex Pharmaceuticals shares in Q1 2026, an estimated $21.9K.
  • Vertex Pharmaceuticals made up 1.64% of Whitney & Co's portfolio in Q1 2026, its #17 holding.
  • Whitney & Co first reported a position in Vertex Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • Whitney & Co's Vertex Pharmaceuticals position peaked at $24M in Q2 2024.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Whitney & Co's 13F filing for Q1 2026, filed 5 May 2026.